Zobrazeno 1 - 10
of 32
pro vyhledávání: '"H. -O. Keinecke"'
Autor:
Johan Decruyenaere, H-O Keinecke, W Ilias, Lg Thijs, H Lignian, W List, H Heinrichs, F Schindel, Sigurd Knaub
Publikováno v:
Intensive Care Medicine, 26, 704-715. Springer Verlag
Ilias, W, List, W, Decruyenaere, J, Lignian, H, Knaub, S, Schindel, F, Keinecke, H O, Heinrichs, H & Thijs, L G 2000, ' Antithrombin III patients with severe sepsis: a pharmacokinetic study. ', Intensive Care Medicine, vol. 26, pp. 704-715 . https://doi.org/10.1007/s001340051236
Ilias, W, List, W, Decruyenaere, J, Lignian, H, Knaub, S, Schindel, F, Keinecke, H O, Heinrichs, H & Thijs, L G 2000, ' Antithrombin III patients with severe sepsis: a pharmacokinetic study. ', Intensive Care Medicine, vol. 26, pp. 704-715 . https://doi.org/10.1007/s001340051236
Objectives: To evaluate the safety, pharmacokinetics, and the practicability of two different antithrombin III (AT III) high-dose regimens in patients with severe sepsis.¶Design: Prospective, open, randomized, 2 parallel groups, multinational clinic
Autor:
G. Emmanuel, S. Carranza, S. Vettichira, M. Paradis, T. Lie, P. Kessler, V. B. Schini-Kerth, Y. Koh, B. M. Hybertson, E. K. Jepson, M. J. Kim, I. Lee, C. M. Lim, S. D. Lee, W. S. Kim, D. S. Kim, W. D. Kim, J. E. Repine, T. Takeda, T. Yukioka, H. Matsuda, S. Shimazaki, D. Kammermeier, J. Birkmann, L. Blinzler, W. M. Gallmeier, D. Heuser, M. Jourdain, J. Mangalaboyi, O. Carrette, A. Toumoys, F. Fourrier, J. Mizon, C. Chopin, S. L. Peake, J. K. Carter, R. G. Russ, J. Pierides, J. P. Leppard, K. Porter, H. F. Galley, N. R. Webster, S. J. Wigmore, T. S. Walsh, P. Hopton, A. Lee, J. A. Ross, P. A. Majcherczyk, J. Pugin, M. P. Glauser, D. Heumann, G. Zanetti, I. de Werra, A. Sablotzki, I. Welters, T. Menges, G. Görlach, N. Lehmann, G. Hempelmann, E. Giannitsis, I. Tettenborn, U. Stierle, K. Dalhoff, A. Sheikhzadeh, K. W. Diederich, V. Gant, C. Maciver, D. F. Treacher, M. Lamy, L. G. Thijs, B. Eisele, H. -O. Keinecke, H. P. Schuster, F. R. Matthias, W. Oettinger, U. Hartenauer, U. Delvos, S. A. Stott, D. W. Noble, W. Schobersberger, G. Hoffmann, J. Fandrey, G. J. Bellingan, H. Caldwell, I. Dransfield, S. M. Howie, C. Haslett, L. Liaudet, F. Feihl, M. Markert, C. Perret, M. A. Williams, C. Rhoades, S. A. White, J. Miller, S. Withington, A. C. Newland, S. M. Kelsey, A. Froon, M. Bonten, C. Gaillard, J. Greve, P. de Leeuw, M. Drent, E. Stobberingh, W. Buurman, O. Fourcade, M. -F. Simon, F. Leballe, R. Ashraf, L. Sarda, B. Cathala, H. Chap, P. Reper, R. Danckaert, R. Jeunen, T. Bruyns, J. De Hemptinne, A. Vanderkelen
Publikováno v:
Intensive Care Medicine. 22:S339-S344
Autor:
T J, Craig, A K, Bewtra, S L, Bahna, D, Hurewitz, L C, Schneider, R J, Levy, J N, Moy, J, Offenberger, K W, Jacobson, W H, Yang, F, Eidelman, G, Janss, F R, Packer, M A, Rojavin, T, Machnig, H-O, Keinecke, R L, Wasserman
Publikováno v:
Allergy. 66(12)
The placebo-controlled study International Multicentre Prospective Angioedema C1-INH Trial 1 (I.M.P.A.C.T.1) demonstrated that 20 U/kg C1 esterase inhibitor (C1-INH) concentrate (Berinert®; CSL Behring, Marburg, Germany) is effective in treating acu
Autor:
B L, Warren, A, Eid, P, Singer, S S, Pillay, P, Carl, I, Novak, P, Chalupa, A, Atherstone, I, Pénzes, A, Kübler, S, Knaub, H O, Keinecke, H, Heinrichs, F, Schindel, M, Juers, R C, Bone, S M, Opal
Publikováno v:
JAMA. 286(15)
Activation of the coagulation system and depletion of endogenous anticoagulants are frequently found in patients with severe sepsis and septic shock. Diffuse microthrombus formation may induce organ dysfunction and lead to excess mortality in septic
Autor:
H-O Keinecke, Maurice Lamy, H. P. Schuster, U. Delvos, F. R. Matthias, F. Fourrier, L. G. Thijs, H. Heinrichs, B. Eisele
Publikováno v:
Intensive care medicine. 24(7)
Objectives: To evaluate the safety and potential efficacy of antithrombin III (AT III) in reducing mortality in patients with severe sepsis. Design: Prospective, randomized, placebo-controlled, double-blind, phase II, multicenter, multinational clini
Autor:
E. Kreuzfelder, H. O. Keinecke, N. H. Brockmeyer, C. Bluhm, Edgar E. Ohnhaus, E. Scheiermann, G. Shen
Publikováno v:
Klinische Wochenschrift. 67(1)
The effect of cimetidine, a histamine H2-receptor antagonist, on the immune system in man was investigated in 11 healthy volunteers. Cimetidine was administered orally in daily doses of 800 mg for a period of 7 days. At the end of the administration
Autor:
E, Kreuzfelder, G, Shen, U, Rodeck, E, König, W, Luboldt, H O, Keinecke, N, Brockmeyer, N, Scheiermann
Publikováno v:
Journal of immunological methods. 97(2)
Lymphocyte subpopulations were determined in blood samples from blood donors (40 women and 45 men) using immunofluorescence microscopy and flow cytometric methodologies. The study demonstrates the value of both methods for the enumeration of lymphocy
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 108(49)
Changes in the expression of T-lymphocyte membrane antigens are seen in many diseases, particularly in autoimmune diseases. The reliability of these parameters, as well as their changes associated with age and sex, were examined in 232 healthy subjec
Autor:
N H, Brockmeyer, E, Kreuzfelder, N, Chalabi, N, Scheiermann, H O, Keinecke, M, Goos, E E, Ohnhaus
Publikováno v:
International journal of clinical pharmacology, therapy, and toxicology. 27(9)
The effect of cimetidine, a histamine H2 receptor antagonist, was investigated in 12 healthy volunteers over a period of six weeks. Cimetidine was administered orally in a daily doses of 1,600 mg during the first three weeks of evaluation. Significan